Ascendis Pharma Change in Accounts Receivable 2015-2025 | ASND
Ascendis Pharma change in accounts receivable for the twelve months ending March 31, 2025 was $-0.043B, a 50.17% decline year-over-year.
- Ascendis Pharma annual change in accounts receivable for 2024 was $-0.128B, a 261.84% increase from 2023.
- Ascendis Pharma annual change in accounts receivable for 2023 was $-0.035B, a 191.96% increase from 2022.
- Ascendis Pharma annual change in accounts receivable for 2022 was $-0.012B, a 54.21% increase from 2021.